Bayer Announces $10.5 Billion Settlement for Roundup Lawsuits; Shares Surge

German chemical giant Bayer has proposed a massive $10.5 billion settlement package to resolve long-standing litigation surrounding its Roundup weedkiller. The comprehensive deal aims to address both current and potential future claims alleging that the product causes non-Hodgkin's lymphoma. Under the terms of the proposal, $7.5 billion will be allocated for class-action and future liabilities over the next 20 years, while $3 billion is earmarked for existing U.S. cases. Following the announcement, Bayer's stock experienced its largest surge in three months as investors welcomed the removal of a significant legal overhang. CEO Bill Anderson is pushing for this resolution to stabilize the company's valuation, which has been pressured since the acquisition of Monsanto. This strategic move is expected to provide a clearer path for the company's core business operations by mitigating multi-year legal risks.